Atrial fibrillation, valvular heart disease, and use of target-specific oral anticoagulants for stroke prevention

被引：7
|
作者：
Hohnloser, Stefan H.
Lopes, Renato D.
机构：
[1] Goethe Univ Frankfurt, Dept Cardiol, D-60590 Frankfurt, Germany
[2] Duke Med, Duke Clin Res Inst, Durham, NC USA
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷 / 47期
关键词：
WARFARIN; DABIGATRAN; APIXABAN;
D O I：
10.1093/eurheartj/ehu386
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This editorial refers to 'Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial'(+), by G. Breithardt et al. on page 3377.
引用
收藏
页码：3323 / 3325
页数：3
相关论文
共 50 条
  • [31] Reversal of target-specific oral anticoagulants
    Kaatz, Scott
    Crowther, Mark
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2013, 36 (02) : 195 - 202
  • [32] Cost-Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation
    Sheldon M. Singh
    Harindra C. Wijeysundera
    [J]. Current Cardiology Reports, 2015, 17
  • [33] Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation
    Durham, Todd A.
    Lich, Kristen Hassmiller
    Viera, Anthony J.
    Fine, Jason P.
    Mukherjee, Jayanti
    Weinberger, Morris
    Dusetzina, Stacie B.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (10): : 1820 - 1829
  • [34] Cost-Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation
    Singh, Sheldon M.
    Wijeysundera, Harindra C.
    [J]. CURRENT CARDIOLOGY REPORTS, 2015, 17 (08)
  • [35] Direct Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves
    Jain, Vardhmaan
    Bhatia, Kirtipal
    Aggarwal, Devika
    Bansal, Agam
    Narasimhan, Bharat
    Hendrickson, Michael J.
    Arora, Sameer
    Ricciardi, Mark J.
    Qamar, Arman
    [J]. STRUCTURAL HEART-THE JOURNAL OF THE HEART TEAM, 2021, 5 (06): : 631 - 633
  • [36] Adoption of direct oral anticoagulants for stroke prevention in atrial fibrillation
    Baker, D.
    Wilsmore, B.
    Narasimhan, S.
    [J]. INTERNAL MEDICINE JOURNAL, 2016, 46 (07) : 792 - 797
  • [37] Stroke Prevention in Atrial Fibrillation: Impact of Novel Oral Anticoagulants
    Haft, Jacob I.
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2013, 19 (03) : 241 - 248
  • [38] Efficacy and Safety of Amiodarone in Patients With Atrial Fibrillation in the Era of Target-Specific Anticoagulants
    Viles-Gonzalez, Juan F.
    Halperin, Jonathan L.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (15) : 1551 - 1553
  • [39] New Anticoagulants for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation
    Hoecht, T.
    Frick, M.
    Alber, H.
    Huber, K.
    [J]. JOURNAL FUR KARDIOLOGIE, 2012, 19 (3-4): : 55 - 62
  • [40] Practical Considerations in the Use of Novel Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation
    Deitelzweig, Steven
    [J]. CARDIOVASCULAR THERAPEUTICS, 2014, 32 (02) : 74 - 81
12345